Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-934-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- August 30, 2004 to September 27, 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- reaction products of ethylene glycol, urea and paraformaldehyde
- EC Number:
- 700-934-5
- Molecular formula:
- No exact molecular formula can be given for a complex reaction mixture (UVCB substance).
- IUPAC Name:
- reaction products of ethylene glycol, urea and paraformaldehyde
- Details on test material:
- - Name of test material (as cited in study report): EUF (TPI 1618)
- Substance type: Formaldehyde releaser
- Physical state: clear colourless liquid
- Analytical purity: Reaction product of urea, etyleneglycol and paraformaldehyde. Therefore purity is not exactly known
- Composition of test material, percentage of components: Reaction product of urea, etyleneglycol and paraformaldehyde. Releasable formaldehyde: 46.1%
- Lot/batch No.: LJ 526/37
- Expiration date of the lot/batch: January 2006
- Storage condition of test material: at room temperature, closed container
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann, Borchen, Germany
- Age at study initiation: 8-12 weeks at delivery
- Weight at study initiation: males:31.0 – 36.6 g; females: 42.7 – 30.2 g
- Assigned to test groups randomly: yes, under following basis: unambiguously identification
- Fasting period before study: 18 hours
- Housing: individually in Macrolon Type II cages
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+-2
- Humidity (%): 55+-15
- Air changes (per hr): 10-20
- Photoperiod: 12 hrs dark / 12 hrs light
IN-LIFE DATES: From September 08, 2004 to September 21, 2004
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Justification for choice of solvent/vehicle: absence of water to maintain a stable solution
- Concentration of test material in vehicle: 3, 6 and 12%
- Amount of vehicle (if gavage): 10 mL/kg bw - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test item was dissolved in corn oil at a 3, 6 and 12% suspension to obtain the required concentrations for the dosing solutions.
Cyclophosphamide was dissolved in water - Duration of treatment / exposure:
- Negative control group: 5 m/5 f; sampling time 24 and 48 h
Positive control group: 5 m/5 f, sampling time 24 h
Low dose group: 5 m/5 f, sampling time 24 h
Mid dose group: 5 m/5 f, sampling time 24 h
High dose group: 5 m/5 f, sampling time 24 and 48 h - Frequency of treatment:
- All animals recieved a single oral treatment by gavage
- Post exposure period:
- 24 h after treatment (all exposure groups and control groups)
48 h after treatment (highest dose group and negative control group)
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day
- Dose / conc.:
- 300 mg/kg bw/day
- Dose / conc.:
- 600 mg/kg bw/day
- Dose / conc.:
- 1 200 mg/kg bw/day
- No. of animals per sex per dose:
- 5 males/5 females
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Justification for choice of positive control(s): to secure the sensitivity of the test system
- Route of administration: oral gavage
- Doses / concentrations: 60 mg/kg bw
Examinations
- Tissues and cell types examined:
- Tissue: Bone marrow
Type of cells: Erythrocytes in bone marrow
Parameter: -Number of micronucleated cells per 2000 polychromatic erythrocytes
-Number of polychromatic erythrocytes per 200 blood cells
-Ratio polychromatic/normochromatic erythrocytes - Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
Doses were selected after a preliminary dose reange finding
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
negative control: 5 males + 5 females per sampling time (24 and 48 h)
positive control: 5 males + 5 females per sampling time (24 h)
Low dose group: 5 m/5 f, sampling time 24 h
Mid dose group: 5 m/5 f, sampling time 24 h
High dose group: 5 m/5 f, sampling time 24 and 48 h
DETAILS OF SLIDE PREPARATION:
Bone marrow smears were prepared and stained according to Pappenheim
METHOD OF ANALYSIS:
Microscopic evaluation - Evaluation criteria:
- A genotoxic effect is claimed if a dose-related increase in the number of polychromatic micronucleated erythrocytes or a statistically significant increase in the number of micronucleated cells in a single dose group at a sampling time is observed, but biological relevance of the results is considered first.
- Statistics:
- U-test according to Mann-Whitney
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: A female animal died at 2000 mg/kg bw, wheras no male animal died. At 1000 mg/kg bw. there were no signs in males or females, however, at 650 mg/kg bw, one male showed clinical signs but recovered within 3 hours.
- Rationale for exposure: In the light of these findings, 300, 600 and 1200 mg/kg bw were chosen for the main study.
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay): no
- Ratio of PCE/NCE (for Micronucleus assay): 48 h after EUF application, male and female animals of the high dose groups demonstrated a slight decrease rather than an increase in the mean frequency of micronucleus formation. The observed reduction in micronucleus formation could be due to slight inhibition of blood formation, indicated by a reduction in the ratio of PCE/200 RBC in the bone marrow of EUF exposed animals
- Appropriateness of dose levels and route: approriate, as clinical signs were observed
- Statistical evaluation: no statistically significant effects
Any other information on results incl. tables
Table 1: Induction of Micronuclei (Number per 2000 PCE, Mean ± SD
Groups/Dosages |
Males |
Females |
Negative controls (24 h) |
4.6 ± 2.7 |
3.2 ± 0.8 |
Positive controls (24 h) |
122.2 ± 14.7 **P<0.01 |
84.6 ± 31.0 **P<0.01 |
300 mg EUF/kg bw (24 h) |
4.6 ± 1.6 |
4.6 ± 1.9 |
600 mg EUF/kg bw (24 h) |
4.6 ± 1.5 |
3.4 ± 1.9 |
1200 mg EUF/kg bw (24 h) |
4.8 ± 2.8 |
4.0 ± 2.0 |
Negative contols (48 h) |
5.4 ± 2.9 |
3.4 ± 2.6 |
1200 mg EUF/kg bw (48 h) |
4.2 ± 2.9 |
2.6 ± 2.4 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
EUF (TPI 1618) is not considered to be clastogenic in vivo in the mouse micronucleus test in the bone marrow cells after a single oral administration - Executive summary:
The study represents a micronucleus assay in bone marrow cells of the mouse with EUF (TPI1618) given once, orally, up to the maximum tolerable dose. The test was performed according to OECD 474 to NMRI mice. Doses used were 300, 600 and 1200 mg/kg bw. Evaluation times were after 24 hours for positive and negative control and for the 300 and 600 mg/kg dose levels. The vehicle control and high dose group (1200 mg/kg bw.) was evaluated 24 and 48 hours post administration.
There was a slight tendency towards inhibition of blood formation especially 48 h after application in the high dose as shown by slightly reduced numbers of polychromatic erythrocytes and PCE/NCE ratios, indicating that some EUF or EUF hydrolytes reached the bone marrow compartment. A lack of DNA reactivity was already observed for some other formaldehyde releasing biocides (Richardson et al., 1983; Charles et al., 2005) and was assigned to formaldehyde detoxification mechanisms existing in vivo which prevent generation of formaldehyde levels capable of causing geno-toxicity at sites others than the direct application site.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
